Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 757 word(s) 757 2020-12-15 07:35:56

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. Progressive Familial Intrahepatic Cholestasis. Encyclopedia. Available online: (accessed on 22 February 2024).
Xu R. Progressive Familial Intrahepatic Cholestasis. Encyclopedia. Available at: Accessed February 22, 2024.
Xu, Rita. "Progressive Familial Intrahepatic Cholestasis" Encyclopedia, (accessed February 22, 2024).
Xu, R. (2020, December 24). Progressive Familial Intrahepatic Cholestasis. In Encyclopedia.
Xu, Rita. "Progressive Familial Intrahepatic Cholestasis." Encyclopedia. Web. 24 December, 2020.
Progressive Familial Intrahepatic Cholestasis

Progressive familial intrahepatic cholestasis (PFIC) is a disorder that causes progressive liver disease, which typically leads to liver failure. In people with PFIC, liver cells are less able to secrete a digestive fluid called bile. The buildup of bile in liver cells causes liver disease in affected individuals.

genetic conditions

1. Introduction

Signs and symptoms of PFIC typically begin in infancy and are related to bile buildup and liver disease. Specifically, affected individuals experience severe itching, yellowing of the skin and whites of the eyes (jaundice), failure to gain weight and grow at the expected rate (failure to thrive), high blood pressure in the vein that supplies blood to the liver (portal hypertension), and an enlarged liver and spleen (hepatosplenomegaly).

There are three known types of PFIC: PFIC1, PFIC2, and PFIC3. The types are also sometimes described as shortages of particular proteins needed for normal liver function. Each type has a different genetic cause.

In addition to signs and symptoms related to liver disease, people with PFIC1 may have short stature, deafness, diarrhea, inflammation of the pancreas (pancreatitis), and low levels of fat-soluble vitamins (vitamins A, D, E, and K) in the blood. Affected individuals typically develop liver failure before adulthood.

The signs and symptoms of PFIC2 are typically related to liver disease only; however, these signs and symptoms tend to be more severe than those experienced by people with PFIC1. People with PFIC2 often develop liver failure within the first few years of life. Additionally, affected individuals are at increased risk of developing a type of liver cancer called hepatocellular carcinoma.

Most people with PFIC3 have signs and symptoms related to liver disease only. Signs and symptoms of PFIC3 usually do not appear until later in infancy or early childhood; rarely, people are diagnosed in early adulthood. Liver failure can occur in childhood or adulthood in people with PFIC3.

2. Frequency

PFIC is estimated to affect 1 in 50,000 to 100,000 people worldwide. PFIC type 1 is much more common in the Inuit population of Greenland and the Old Order Amish population of the United States.

3. Causes

Mutations in the ATP8B1, ABCB11, and ABCB4 genes can cause PFIC.

ATP8B1 gene mutations cause PFIC1. The ATP8B1 gene provides instructions for making a protein that helps to maintain an appropriate balance of bile acids, a component of bile. This process, known as bile acid homeostasis, is critical for the normal secretion of bile and the proper functioning of liver cells. In its role in maintaining bile acid homeostasis, some researchers believe that the ATP8B1 protein is involved in moving certain fats across cell membranes. Mutations in the ATP8B1 gene result in the buildup of bile acids in liver cells, damaging these cells and causing liver disease. The ATP8B1 protein is found throughout the body, but it is unclear how a lack of this protein causes short stature, deafness, and other signs and symptoms of PFIC1.

Mutations in the ABCB11 gene are responsible for PFIC2. The ABCB11 gene provides instructions for making a protein called the bile salt export pump (BSEP). This protein is found in the liver, and its main role is to move bile salts (a component of bile) out of liver cells. Mutations in the ABCB11 gene result in the buildup of bile salts in liver cells, damaging these cells and causing liver disease.

ABCB4 gene mutations cause PFIC3. The ABCB4 gene provides instructions for making a protein that moves certain fats called phospholipids across cell membranes. Outside liver cells, phospholipids attach (bind) to bile acids. Large amounts of bile acids can be toxic when they are not bound to phospholipids. Mutations in the ABCB4 gene lead to a lack of phospholipids available to bind to bile acids. A buildup of free bile acids damages liver cells and leads to liver disease.

Some people with PFIC do not have a mutation in the ATP8B1, ABCB11, or ABCB4 gene. In these cases, the cause of the condition is unknown.

4. Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

5. Other Names for This Condition

  • ABCB11-related intrahepatic cholestasis
  • ABCB4-related intrahepatic cholestasis
  • ATP8B1-related intrahepatic cholestasis
  • BSEP deficiency
  • Byler disease
  • Byler syndrome
  • FIC1 deficiency
  • low γ-GT familial intrahepatic cholestasis
  • MDR3 deficiency


  1. Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepaticcholestasis. J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):241-52. doi:10.1097/MPG.0b013e3181596060. Review.
  2. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familialintrahepatic cholestasis. Orphanet J Rare Dis. 2009 Jan 8;4:1. doi:10.1186/1750-1172-4-1. Review.
  3. Harris MJ, Le Couteur DG, Arias IM. Progressive familial intrahepaticcholestasis: genetic disorders of biliary transporters. J Gastroenterol Hepatol. 2005 Jun;20(6):807-17. Review.
  4. Jansen PL, Sturm E. Genetic cholestasis, causes and consequences forhepatobiliary transport. Liver Int. 2003 Oct;23(5):315-22. Review.
  5. Knisely AS, Bull LN, Shneider BL. ATP8B1 Deficiency. 2001 Oct 15 [updated 2014Mar 20]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K,Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University ofWashington, Seattle; 1993-2020. Available from
  6. Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005Aug;43(2):342-57. Review.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 328
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020